However, conditional deletion of Spi1 under the control of CD19-Cre on a Spib-/- (CD19-CreΔPB) background leads to severely impaired B cell development and B cell acute lymphoblastic leukemia, which is partially attributed to loss of Blnk [9,17]. The gene discussed is CD19; the disease is B-cell acute lymphoblastic leukemia.